Literature DB >> 35412453

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.

Giacomo Sgalla1, Tonia Magrì2, Marialessia Lerede2, Alessia Comes2, Luca Richeldi2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35412453     DOI： 10.1164/rccm.202112-2765LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  2 in total

1.  Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination.

Authors:  Masashi Sakayori; Eri Hagiwara; Tomohisa Baba; Hideya Kitamura; Akimasa Sekine; Satoshi Ikeda; Erina Tabata; Sho Yamada; Kazushi Fujimoto; Takashi Ogura
Journal:  J Infect Chemother       Date:  2022-09-13       Impact factor: 2.065

2.  Coronavirus disease 2019 vaccination-induced acute exacerbation in idiopathic pulmonary fibrosis.

Authors:  Keishi Sugino; Hirotaka Ono; Mikako Saito; Masahiro Ando; Eiyasu Tsuboi
Journal:  Respirol Case Rep       Date:  2022-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.